Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
7
×
life sciences
national blog main
national top stories
boston top stories
new york blog main
new york top stories
san francisco blog main
san francisco top stories
biotech
san diego blog main
san diego top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
deals
detroit blog main
detroit top stories
indiana blog main
indiana top stories
national
raleigh-durham blog main
raleigh-durham top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
fda
abbvie
alnylam pharmaceuticals
gene therapy
hemophilia
imara
novartis
rna
sanofi
startups
takeda pharmaceutical
What
help
7
×
drug
bio
patients
roundup
approved
disease
fda
gene
long
medicine
news
therapy
treatment
acorda
acquisitions
adu
alzheimer's
analytics
announced
aren’t
bad
beats
bids
biofourmis
biogen
brain
cancer
case
ceo
collabs
complicated
cope
covid
crude
cutting
daniel
data
deal
depression
Language
unset
Current search:
help
×
" boston blog main "
×
@xconomy.com
3 years ago
Biofourmis Hauls In $100M to Scale Digital Therapeutics Globally
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Encoded Nabs $104M, Illumina’s Help, to Push Gene Therapy’s Limits
@xconomy.com
5 years ago
Can Tiny Drug Doses (and One Woman’s Fortune) Fight the Most Vicious Cancer?
@xconomy.com
5 years ago
Bio Roundup: Sage Postpartum Help, Biogen Bids Adu, Heart Beats & More
@xconomy.com
5 years ago
Acorda Gets FDA Nod For New Parkinson’s Drug, But Rival Looms
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More